Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #451 to #500.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Itolizumab (2 links)
  2. Ixekizumab (2 links)
  3. Juvenile Idiopathic Arthritis (2 links)
  4. KIR2D (2 links)
  5. KLRC1 (2 links)
  6. Kallikrein (2 links)
  7. Keliximab (2 links)
  8. L-selectin (2 links)
  9. LFA-1 (2 links)
  10. LOXL2 (2 links)
  11. Labetuzumab (2 links)
  12. Lampalizumab (2 links)
  13. Lanadelumab (2 links)
  14. Landogrozumab (2 links)
  15. Laprituximab emtansine (2 links)
  16. Lebrikizumab (2 links)
  17. Lemalesomab (2 links)
  18. Lendalizumab (2 links)
  19. Lentivirus Concentration PEG (2 links)
  20. Lenzilumab (2 links)
  21. Lerdelimumab (2 links)
  22. Leukemia (2 links)
  23. Lewis antigen system (2 links)
  24. Lexatumumab (2 links)
  25. Libivirumab (2 links)
  26. Lifastuzumab vedotin (2 links)
  27. Ligelizumab (2 links)
  28. Lintuzumab (2 links)
  29. Lipoteichoic acid (2 links)
  30. Lirilumab (2 links)
  31. Lodelcizumab (2 links)
  32. Lokivetmab (2 links)
  33. Lorvotuzumab mertansine (2 links)
  34. Lucatumumab (2 links)
  35. Lulizumab pegol (2 links)
  36. Lumiliximab (2 links)
  37. Lumretuzumab (2 links)
  38. Lutetium (177 Lu) lilotomab satetraxetan (2 links)
  39. Lymphoma (2 links)
  40. Lymphotoxin alpha (2 links)
  41. MABp1 (2 links)
  42. MBP,MMLV,UDG Protein Screening (2 links)
  43. MCP-1 (2 links)
  44. MS4A1 (2 links)
  45. MUC1 (2 links)
  46. Macrophage migration inhibitory factor (2 links)
  47. Macular degeneration (2 links)
  48. Mapatumumab (2 links)
  49. Margetuximab (2 links)
  50. Maslimomab (2 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://eln.excellgen.com/index.php?title=Special:MostLinkedPages"